The size of the European protein labelling market is projected to grow USD 0.78 billion by 2027 and USD 0.45 billion in 2022, growing at a CAGR of 11.74% during the forecast period.
The European protein labelling market is primarily driven by a strong trend of rising healthcare expenditures. Increased R&D spending and expansion in proteomics research are two more major reasons. Protein labelling is more widely used in vitro, in vivo, and biorthogonal labelling methods, leading to market expansion. Smaller businesses are entering the market with customized protein labelling kits, while larger companies are focusing on new product launches tailored to meet the needs of researchers. Furthermore, the main players have expanded their product range and R&D operations in this market by acquiring individual and private businesses. The most common applications of protein labelling include the research of biological processes, the management of multiplexed samples using protein modifications, and the accurate quantification and identification of isomers. It is advised to evaluate as essentiality for proteomic profiling before analyzing and separating amino acids or proteins.
Protein labelling is becoming increasingly popular. Protein labelling employs a short tag to prevent protein folding and function from being disrupted. Immunochemistry, fluorescence in situ hybridization (FISH), cell tracking, receptor labelling, and fluorescence spectroscopy are just a few of the uses for these fluorescent proteins. As a result of the growing number of applications, the market for protein labelling is expected to expand even more in the future. Strategic collaborations are helping companies in the protein labelling sector improve their product innovation. Firms produce novel goods and exchange skills and expertise with other companies to stay alive in an increasingly competitive market. The use of labels in the detection and purification of proteins and diagnostic tests based on the detection of a specific protein has risen considerably due to the use of bioengineering techniques. Advancements in mass spectrometry for biomarker discovery and quantification for illness prediction are likely to open up attractive business opportunities. In the Europe Protein Labeling market, technical advancements and upcoming innovations such as computer-controlled fluorescence systems and laser-confocal microscopy provide opportunities.
Because of the constraints of labeled techniques, such as wet-lab complexity and flexibility, label-free approaches are favored. While label-free samples may be measured without any preparation, all labelling procedures need wet lab pre-treatment. The market's expansion is also being hampered by a lack of skilled professionals and insufficient applications of protein-labeling products.
The European protein labelling market has several challenges, including irregularity in protein labelling methods and strict regulatory restrictions.
This research report on the Europe Protein Labelling Market has been segmented and sub-segmented into the following categories:
In Europe, Germany leads the Protein labeling market, followed by France and U.K. The market in this region is projected to grow strongly during the forecast period due to various factors such as growing health awareness, financial strength to procure expensive tools, and favorable reimbursement policies. As a result, the European market has a global share of 26% and has a CAGR of 11.74%.
While riding on an increasing number of proteomics research studies, Europe may share the largest share in coming years. The proteomics area has benefited from this rise in R&D investment since it has broadened the applicability of mass spectrometry, protein microarrays, and biochips in this field. Proteomics applications are also driven by advances in mass spectrometry processes and the miniaturization of biochips, which drive the market's organic revenue growth. In addition, drug development, diagnostic, and therapeutic applications benefit from the use of current molecular biology and bioengineering technologies to better understand functional processes on a subcellular scale, both under pathologic and physiologic conditions. Furthermore, the region's revenue growth is expected to be aided by the rising usage of customized medicine and genetic sequencing throughout the forecast period.
KEY MARKET PLAYERS:
A few of the prominent companies leading the Europe Protein Labelling Market profiled in the report are Thermo Fisher Scientific, Inc., General Electric Company, Merck KGaA, Eurogentec S.A., PerkinElmer, Inc., F. Hoffmann-La Roche AG, New England Biolabs, Kaneka Corporation, Kirkegaard & Perry Laboratories, Promega Corporation, LI-COR, Inc. and SeraCare Life Sciences, Inc.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org